Business Wire

LTIMindtree’s FY25 Revenue up 7% in INR

Share

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the fourth quarter and full year ended Mar 31, 2025, as approved by its Board of Directors.

“We concluded FY25 with a revenue growth of 5% in constant currency terms and an EBIT margin of 14.5%. Our key verticals and a major geography drove our yearly growth despite an ongoing challenging macro environment. The robust order inflow, driven by a significant array of AI-led deal wins, illustrates the pervasive integration of AI across our service offerings.

Venu Lambu’s transition to LTIMindtree has been seamless and supports our strategic goals. His growing understanding of the organisation, combined with our ability to secure large deals, strong presence in tech-intensive sectors, and robust balance sheet, positions us well to leverage the opportunities ahead of us.”
- Debashis Chatterjee, Chief Executive Officer and Managing Director

Key financial highlights:

Quarter ended Mar 31, 2025

In USD:

- Revenue at $1,131.0 million (-0.7% Q-o-Q / +5.8% Y-o-Y)
- Operating Margin (EBIT) at 13.8%
- Net profit at $130.6 million (+2.0% Q-o-Q / -1.4% Y-o-Y)

In INR:

- Revenue at Rs. 97,717 million (+1.1% Q-o-Q / +9.9% Y-o-Y)
- Net profit at Rs. 11,286 million (+3.9% Q-o-Q / +2.5% Y-o-Y)

Year ended Mar 31, 2025

In USD:

- Revenue at $4,492.5 million (+4.8% Y-o-Y)
- Operating Margin (EBIT) at 14.5%
- Net profit at $543.9 million (-1.7% Y-o-Y)

In INR:

- Revenue at Rs. 3,80,081 million (+7.0% Y-o-Y)
- Net profit at Rs. 46,020 million (+0.4% Y-o-Y)

Other highlights:

Clients:

- 741 active clients as of Mar 31, 2025
- $5 million+ clients increased by 1 on a Y-o-Y basis, total 154
- $50 million+ clients increased by 1 on a Y-o-Y basis, total 14

People:

- 84,307 professionals as of Mar 31, 2025
- Trailing 12 months attrition was 14.4%

Deal Wins

  • A leading US life insurance company has engaged LTIMindtree to enhance its quality processes using AI to improve the operating model, thereby advancing enterprise quality engineering maturity. This is a multi-year deal which will focus on enhancing quality engineering practices and leveraging AI to transform the operating model.
  • LTIMindtree has been selected by a global Energy major to provide NextGen ERP Support services across multiple functional and SaaS-based solutions.
  • A leading global financial institution has chosen LTIMindtree for its Data Center Migration Project. The deal encompasses the development of comprehensive infrastructure designs and architecture aimed at maximizing performance while minimizing the total cost of operations.
  • LTIMindtree secured an Application Managed Services deal from a leading North American utility company. LTIMindtree’s business-first approach will help the customer achieve quality at scale while improving cost efficiency and productivity.
  • LTIMindtree was chosen by a global reinsurance group to enhance efficiency through an AI Ops model as part of its end-to-end outsourcing deal.
  • A prominent life sciences company in North America has chosen LTIMindtree to undertake its Oracle implementation and maintenance project, ensuring an optimal delivery mix.
  • A leading US materials and construction company has engaged LTIMindtree to maintain and support its complex legacy ERP system as part of its digital transformation initiative.
  • A leading digital company in the KSA region has entrusted LTIMindtree with providing end-to-end operations services for their hybrid cloud security platform.

Partnerships

  • LTIMindtree and Google announced a Strategic Partnership to drive Business Transformation with Agentic AI. LTIMindtree will leverage offerings powered by Google Cloud technology using Agentic AI to redefine the cloud landscape for clients worldwide and drive broad-based GenAI adoption.
  • LTIMindtree has successfully achieved revalidation as an AWS Managed Services Provider (MSP) for the year 2024. The AWS MSP program is a worldwide initiative by AWS that recognizes and showcases the most proficient cloud partners with a demonstrated history and expertise in delivering comprehensive AWS solutions.
  • LTIMindtree has been recognized as the "Highest Overall SAP Qualified Pipeline" partner in the SI category at the AWS Champions Club UKI, marking our second consecutive win following our previous success in GenAI. This recognition underscores our strong momentum in SAP on AWS, leveraging both "RISE with SAP" and AWS-native customer journeys.
  • LTIMindtree is now accredited in the Salesforce Tableau Alliance, enabling dedicated resources for collaboration and a focus on joint Tableau customers. This partnership also grants early access to beta versions of products, coinciding with Salesforce's launch of the updated Tableau Next product suite, which is integrated into the Data Cloud.
  • LTIMindtree was awarded the Global Innovation Partner of the Year by Informatica, a significant accomplishment in our inaugural year as a GSI Partner. This honour reflects the strength of our collaboration with Informatica and our mutual commitment to advancing Data & AI transformation for our clients.

Recognitions

  • LTIMindtree recognized as a Strong Performer in Forrester’s 'The Modern Application Development Services Wave, Q1 2025.’
  • LTIMindtree recognized as a Contender in Forrester’s 'The Application Modernization and Multicloud Managed Services Wave, Q1 2025.’
  • LTIMindtree recognized as an Enterprise Innovator in HFS Horizon’s ‘The Salesforce Service Providers, 2025.’
  • LTIMindtree recognized as an Enterprise Innovator in HFS Horizon’s ‘The Generative Enterprise Services, 2025.’
  • LTIMindtree recognized as a Major Contender in Everest Group’s ‘SAP Business Application Services PEAK Matrix® Assessment 2025.’
  • LTIMindtree recognized as a Major Contender in Everest Group’s ‘Industry 4.0 Services PEAK Matrix® Assessment 2025.’
  • LTIMindtree positioned as a Leader in ISG’s Provider Lens™ evaluation for Oracle Cloud and Technology Ecosystem 2024 across all quadrants, US and Europe.

Announcements

The Board of Directors has recommended a final dividend of Rs. 45 per equity share of par value Rs. 1 each for the financial year ended March 31, 2025.

About LTIMindtree

LTIMindtree is a global technology consulting and digital solutions company that enables enterprises across industries to reimagine business models, accelerate innovation, and maximize growth by harnessing digital technologies. As a digital transformation partner to more than 700 clients, LTIMindtree brings extensive domain and technology expertise to help drive superior competitive differentiation, customer experiences, and business outcomes in a converging world. Powered by 84,000+ talented and entrepreneurial professionals across more than 40 countries, LTIMindtree — a Larsen & Toubro Group company — solves the most complex business challenges and delivers transformation at scale. For more information, please visit https://www.ltimindtree.com/.

Earnings Conference Call

Universal Dial-in

+91 22 6280 1157

+91 22 7115 8058

International Toll Free

USA

UK

Singapore

Hong Kong

: 18667462133

: 08081011573

: 8001012045

: 800964448

Replay of Conference Call

Available after 1 hour from the call end time until Apr 24th, 2025

Playback Code: 51903

Dial-in Number: India +91 22 71945757

Audio Webcast

The audio from the conference call will be available online through a webcast and can be accessed at the following link: Click here for Audio Webcast

Click here for your DiamondPass™

DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.

If you have a DiamondPass™, click the above link to associate your pin and receive the access details for this conference. If you do not have a DiamondPass™, please register through the link and you will receive your DiamondPass™ for this conference.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250423101232/en/

Contacts

Media Relations Contact:shambhavi.revandkar@ltimindtree.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release

Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap

DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm

Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press Release

Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly three years, while adding a seasoned in-country team spanning operations, support, sales, finance, and leadership to enable rapid integration and future growth. The E

Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press Release

Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which translate into thinner, more discreet and comfortable products. Its high compression capability enables s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye